These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

236 related items for PubMed ID: 26413815

  • 1. Differential expression and biochemical activity of the immune receptor Tim-3 in healthy and malignant human myeloid cells.
    Gonçalves Silva I, Gibbs BF, Bardelli M, Varani L, Sumbayev VV.
    Oncotarget; 2015 Oct 20; 6(32):33823-33. PubMed ID: 26413815
    [Abstract] [Full Text] [Related]

  • 2. The immune receptor Tim-3 mediates activation of PI3 kinase/mTOR and HIF-1 pathways in human myeloid leukaemia cells.
    Prokhorov A, Gibbs BF, Bardelli M, Rüegg L, Fasler-Kan E, Varani L, Sumbayev VV.
    Int J Biochem Cell Biol; 2015 Feb 20; 59():11-20. PubMed ID: 25483439
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. A TIM-3/Gal-9 Autocrine Stimulatory Loop Drives Self-Renewal of Human Myeloid Leukemia Stem Cells and Leukemic Progression.
    Kikushige Y, Miyamoto T, Yuda J, Jabbarzadeh-Tabrizi S, Shima T, Takayanagi S, Niiro H, Yurino A, Miyawaki K, Takenaka K, Iwasaki H, Akashi K.
    Cell Stem Cell; 2015 Sep 03; 17(3):341-52. PubMed ID: 26279267
    [Abstract] [Full Text] [Related]

  • 5. Suppression of the proliferation of hypoxia-Induced retinal pigment epithelial cell by rapamycin through the /mTOR/HIF-1α/VEGF/ signaling.
    Liu NN, Zhao N, Cai N.
    IUBMB Life; 2015 Jun 03; 67(6):446-52. PubMed ID: 25988388
    [Abstract] [Full Text] [Related]

  • 6. Identification of TIM-3 as a Leukemic Stem Cell Surface Molecule in Primary Acute Myeloid Leukemia.
    Kikushige Y, Miyamoto T.
    Oncology; 2015 Jun 03; 89 Suppl 1():28-32. PubMed ID: 26551150
    [Abstract] [Full Text] [Related]

  • 7. Tim-3 is highly expressed in T cells in acute myeloid leukemia and associated with clinicopathological prognostic stratification.
    Li C, Chen X, Yu X, Zhu Y, Ma C, Xia R, Ma J, Gu C, Ye L, Wu D.
    Int J Clin Exp Pathol; 2014 Jun 03; 7(10):6880-8. PubMed ID: 25400771
    [Abstract] [Full Text] [Related]

  • 8. Hypothesis: Tim-3/galectin-9, a new pathway for leukemia stem cells survival by promoting expansion of myeloid-derived suppressor cells and differentiating into tumor-associated macrophages.
    Gao L, Yu S, Zhang X.
    Cell Biochem Biophys; 2014 Sep 03; 70(1):273-7. PubMed ID: 24639110
    [Abstract] [Full Text] [Related]

  • 9. TIM-3 is a promising target to selectively kill acute myeloid leukemia stem cells.
    Kikushige Y, Shima T, Takayanagi S, Urata S, Miyamoto T, Iwasaki H, Takenaka K, Teshima T, Tanaka T, Inagaki Y, Akashi K.
    Cell Stem Cell; 2010 Dec 03; 7(6):708-17. PubMed ID: 21112565
    [Abstract] [Full Text] [Related]

  • 10. RepSox slows decay of CD34+ acute myeloid leukemia cells and decreases T cell immunoglobulin mucin-3 expression.
    Jajosky AN, Coad JE, Vos JA, Martin KH, Senft JR, Wenger SL, Gibson LF.
    Stem Cells Transl Med; 2014 Jul 03; 3(7):836-48. PubMed ID: 24855276
    [Abstract] [Full Text] [Related]

  • 11. Differential control of hypoxia-inducible factor 1 activity during pro-inflammatory reactions of human haematopoietic cells of myeloid lineage.
    Gibbs BF, Yasinska IM, Pchejetski D, Wyszynski RW, Sumbayev VV.
    Int J Biochem Cell Biol; 2012 Nov 03; 44(11):1739-49. PubMed ID: 22728164
    [Abstract] [Full Text] [Related]

  • 12. Proteolytic Cleavage of AMPKα and Intracellular MMP9 Expression Are Both Required for TLR4-Mediated mTORC1 Activation and HIF-1α Expression in Leukocytes.
    Zhang Z, Amorosa LF, Coyle SM, Macor MA, Lubitz SE, Carson JL, Birnbaum MJ, Lee LY, Haimovich B.
    J Immunol; 2015 Sep 01; 195(5):2452-60. PubMed ID: 26232429
    [Abstract] [Full Text] [Related]

  • 13. Quantitative expression of Toll-like receptor-2, -4, and -9 in dendritic cells generated from blasts of patients with acute myeloid leukemia.
    Schmitt A, Li L, Giannopoulos K, Greiner J, Reinhardt P, Wiesneth M, Schmitt M.
    Transfusion; 2008 May 01; 48(5):861-70. PubMed ID: 18208411
    [Abstract] [Full Text] [Related]

  • 14. Liquiritigenin inhibits serum-induced HIF-1α and VEGF expression via the AKT/mTOR-p70S6K signalling pathway in HeLa cells.
    Xie SR, Wang Y, Liu CW, Luo K, Cai YQ.
    Phytother Res; 2012 Aug 01; 26(8):1133-41. PubMed ID: 22170854
    [Abstract] [Full Text] [Related]

  • 15. Silibinin inhibits hypoxia-inducible factor-1alpha and mTOR/p70S6K/4E-BP1 signalling pathway in human cervical and hepatoma cancer cells: implications for anticancer therapy.
    García-Maceira P, Mateo J.
    Oncogene; 2009 Jan 22; 28(3):313-24. PubMed ID: 18978810
    [Abstract] [Full Text] [Related]

  • 16. Effects of stem cell factor on hypoxia-inducible factor 1 alpha accumulation in human acute myeloid leukaemia and LAD2 mast cells.
    Gibbs BF, Yasinska IM, Oniku AE, Sumbayev VV.
    PLoS One; 2011 Jan 22; 6(7):e22502. PubMed ID: 21799876
    [Abstract] [Full Text] [Related]

  • 17. Tim-3/galectin-9 signaling pathway mediates T-cell dysfunction and predicts poor prognosis in patients with hepatitis B virus-associated hepatocellular carcinoma.
    Li H, Wu K, Tao K, Chen L, Zheng Q, Lu X, Liu J, Shi L, Liu C, Wang G, Zou W.
    Hepatology; 2012 Oct 22; 56(4):1342-51. PubMed ID: 22505239
    [Abstract] [Full Text] [Related]

  • 18. The Galectin-9/Tim-3 pathway is involved in the regulation of NK cell function at the maternal-fetal interface in early pregnancy.
    Li YH, Zhou WH, Tao Y, Wang SC, Jiang YL, Zhang D, Piao HL, Fu Q, Li DJ, Du MR.
    Cell Mol Immunol; 2016 Jan 22; 13(1):73-81. PubMed ID: 25578313
    [Abstract] [Full Text] [Related]

  • 19. Negative regulation of TIM-3 expression in AML cell line (HL-60) using miR-330-5p.
    Fooladinezhad H, Khanahmad H, Ganjalikhani-Hakemi M, Doosti A.
    Br J Biomed Sci; 2016 Jul 22; 73(3):129-133. PubMed ID: 27341144
    [Abstract] [Full Text] [Related]

  • 20. Notoginsenoside Ft1 promotes angiogenesis via HIF-1α mediated VEGF secretion and the regulation of PI3K/AKT and Raf/MEK/ERK signaling pathways.
    Shen K, Ji L, Gong C, Ma Y, Yang L, Fan Y, Hou M, Wang Z.
    Biochem Pharmacol; 2012 Sep 15; 84(6):784-92. PubMed ID: 22771629
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.